Women Infertility – Pipeline by Competitor Information, Analysis, and Insights to Formulate Effective R&D Strategies 2017

WiseGuyReports.com adds Exclusive Research on “Women Infertility” reports to its database.

PUNE, INDIA - October 13, 2017 /MarketersMedia/ —

SUMMARY

WiseGuyReports published new report, titled “Women Infertility - Pipeline Review, H2”

Pharmaceutical and Healthcare disease pipeline guide Women Infertility - Pipeline Review, H2 2017, provides an overview of the Women Infertility (Women's Health) pipeline landscape.
Infertility refers to failure to conceive over the course of one full year. Women infertility is caused due to damage of fallopian tubes, ovulation disorders (polycystic ovary syndrome) and endometriosis. Symptoms include abnormal periods, weight gain, back pain, pelvic pain, and cramping. Risk factor of infertility includes smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes medications to stimulate ovulation and hormone therapies.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385306-women-infertility-pipeline-review-h2-2017

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Women Infertility - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Women Infertility (Women's Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2, 7, 16, 14, 1, 22, 9 and 5 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 2, 5 and 3 molecules, respectively.
Women Infertility (Women's Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Women Infertility (Women's Health).
- The pipeline guide reviews pipeline therapeutics for Women Infertility (Women's Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Women Infertility (Women's Health) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Women Infertility (Women's Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Women Infertility (Women's Health)

Key points to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Women Infertility (Women's Health).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Women Infertility (Women's Health) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents
Introduction
Women Infertility - Overview
Women Infertility - Therapeutics Development
Women Infertility - Therapeutics Assessment
Women Infertility - Companies Involved in Therapeutics Development
Women Infertility - Drug Profiles
Women Infertility - Dormant Projects
Women Infertility - Discontinued Products

..CONTINUED

About Us

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: wiseguyreports
Address: Office No. 528, Amanora Chambers Pune - 411028 Maharashtra, India
Phone: +44 208 133 9349

Source URL: https://marketersmedia.com/women-infertility-pipeline-by-competitor-information-analysis-and-insights-to-formulate-effective-rd-strategies-2017/249960

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 249960

Latest News

Gunmen kill 2 polio workers in Pakistan, mother and daughter

Jan 19, 2018

QUETTA, Pakistan — Gunmen shot and killed a mother and her daughter who were working for an anti-polio campaign underway in Pakistan's southwestern city of Quetta on Thursday, police said. The attack took place as hundreds of polio teams were vaccinating children against the crippling disease, police official Naseeb Ullah said. Pakistan this week launched a drive against polio across the country. In a separate attack in Quetta, the capital of Baluchistan province, assailants killed two policemen. Prime Minister Shahid Khaqan Abbasi condemned the attacks. There was no immediate claim of responsibility for either attack. Pakistan, Afghanistan and Nigeria are...

Pakistan launches new anti-polio drive in Punjab province

Jan 19, 2018

LAHORE, Pakistan — A Pakistani health official says a special anti-polio drive has been launched in the country's eastern Punjab province. Imran Nazir says the week-long campaign was launched on Monday amid tight security. He says thousands of workers are taking part in the drive by going house-to-house to vaccinate children in the struggle to eradicate the crippling disease. Pakistan, Afghanistan and Nigeria are the only three countries left in the world where polio has not been eliminated. Pakistan regularly launches anti-polio drives despite threats from the Taliban who perceive the campaign as part of a Western conspiracy and claim...

Iran oil tanker explodes, sinks off China with no survivors

Jan 19, 2018

TEHRAN, Iran — A burning Iranian oil tanker exploded and sank Sunday after more than a week listing off the coast of China, as an Iranian official acknowledged there was "no hope" of missing sailors surviving the disaster. The collision and disaster of the Sanchi, which carried 30 Iranians and two Bangladeshis, had transfixed an Iran still reeling from days of protests and unrest that swept the country at the start of the year. Families of the sailors wept and screamed at the headquarters of the National Iranian Tanker Co. in Tehran, the private company that owns the Sanchi. Some...

Aid group projects 48,000 births in crowded Rohingya camps

Jan 19, 2018

DHAKA, Bangladesh — An aid agency projects 48,000 babies will be born this year in the refugee camps for Rohingya Muslims who have fled to Bangladesh after military operations against them in Myanmar. The babies will probably be born in tents in unsanitary conditions and will be at increased risk of disease and malnutrition, and of dying before age 5, Save the Children warned in its report Friday. "The camps have poor sanitation and are a breeding ground for diseases like diphtheria, measles and cholera, to which newborn babies are particularly vulnerable," said Rachael Cummings, the agency's health adviser in...

India's new 'driverless' metro train keeps driver for now

Jan 19, 2018

NEW DELHI — India's capital launched a metro train with driverless technology Monday, though officials said it would operate with a driver for at least a year or two. Prime Minister Narendra Modi took an inaugural ride on a short section of the 12.6-kilometer (7.8-mile) Magenta Line, which connects the southern part of New Delhi with the satellite city of Noida, an IT hub across the Yamuna river. The Delhi Metro Rail Corp. has said the highly automated train will run initially with a driver but could become driverless in the future. An official told the Indian Express newspaper that...

Sign up now!

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us: sales@recentdiscovery.com